Trial intelligence / Profile preview

GSK2798745 in Heart Failure

NCT02497937Phase 2Completed

Sponsor
GSK
Start
Apr 2016
Primary completion
Aug 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of GSK2798745 in heart failure (HF), sponsored by GSK. Started Apr 2016; status: completed.

02

Drugs

GSK2798745
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT02497937.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02497937.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call